好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

A Phase II Trial of Mitoxantrone in Patients with Primary Progressive Multiple Sclerosis
004
Authors/Disclosures
No disclosure on file
No disclosure on file
No disclosure on file
Diane Lawson No disclosure on file
Clifford B. Saper, MD, PhD, FAAN (Beth Israel Deaconess Med Ctr) Dr. Saper has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Neurological Association. The institution of Dr. Saper has received research support from NIH. The institution of Dr. Saper has received research support from Mathers Foundation. The institution of Dr. Saper has received research support from Tsukuba University. Dr. Saper has received publishing royalties from a publication relating to health care. Dr. Saper has received publishing royalties from a publication relating to health care. Dr. Saper has a non-compensated relationship as a Treasurer with American Neurological Association that is relevant to AAN interests or activities.